Coastline Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2M Buy
20,897
+672
+3% +$681K 1.91% 12
2025
Q4
$21.7M Buy
20,225
+2,166
+12% +$2.07M 2.04% 12
2025
Q3
$13.8M Sell
18,059
-314
-2% -$234K 1.48% 19
2025
Q2
$14.3M Sell
18,373
-25
-0.1% -$19.4K 1.64% 17
2025
Q1
$15.2M Sell
18,398
-264
-1% -$220K 1.89% 13
2024
Q4
$14.4M Sell
18,662
-209
-1% -$173K 1.69% 13
2024
Q3
$16.7M Sell
18,871
-1,981
-10% -$1.78M 1.96% 11
2024
Q2
$18.9M Sell
20,852
-52
-0.2% -$41.6K 2.21% 10
2024
Q1
$16.3M Buy
20,904
+1,150
+6% +$818K 1.97% 11
2023
Q4
$11.5M Buy
19,754
+909
+5% +$531K 1.53% 12
2023
Q3
$10.1M Sell
18,845
-1,400
-7% -$721K 1.49% 13
2023
Q2
$9.49M Buy
20,245
+1,235
+6% +$518K 1.33% 13
2023
Q1
$6.53M Buy
19,010
+2,350
+14% +$793K 0.97% 20
2022
Q4
$6.09M Buy
16,660
+8,030
+93% +$2.85M 0.91% 26
2022
Q3
$2.79M Buy
8,630
+1,300
+18% +$412K 0.45% 72
2022
Q2
$2.38M Sell
7,330
-235
-3% -$70.5K 0.35% 98
2022
Q1
$2.17M Sell
7,565
-791
-9% -$204K 0.26% 131
2021
Q4
$2.31M Hold
8,356
0.26% 129
2021
Q3
$1.93M Sell
8,356
-320
-4% -$79K 0.24% 139
2021
Q2
$1.99M Sell
8,676
-30
-0.3% -$6.03K 0.25% 138
2021
Q1
$1.63M Sell
8,706
-3,294
-27% -$644K 0.21% 158
2020
Q4
$2.03M Buy
12,000
+920
+8% +$137K 0.27% 127
2020
Q3
$1.64M Buy
11,080
+3,810
+52% +$590K 0.25% 135
2020
Q2
$1.19M Sell
7,270
-200
-3% -$30.7K 0.19% 170
2020
Q1
$1.04M Sell
7,470
-1,975
-21% -$271K 0.19% 174
2019
Q4
$1.24M Buy
9,445
+141
+2% +$16.3K 0.17% 183
2019
Q3
$1.04M Buy
9,304
+359
+4% +$40K 0.15% 196
2019
Q2
$991K Sell
8,945
-670
-7% -$78.9K 0.14% 197
2019
Q1
$1.25M Sell
9,615
-2,000
-17% -$243K 0.19% 178
2018
Q4
$1.34M Hold
11,615
0.23% 153
2018
Q3
$1.25M Sell
11,615
-3,277
-22% -$328K 0.18% 186
2018
Q2
$1.27M Hold
14,892
0.19% 171
2018
Q1
$1.15M Buy
14,892
+390
+3% +$31.4K 0.18% 175
2017
Q4
$1.23M Buy
14,502
+3,175
+28% +$270K 0.18% 165
2017
Q3
$969K Hold
11,327
0.17% 173
2017
Q2
$933K Buy
11,327
+1,770
+19% +$144K 0.17% 176
2017
Q1
$804K Hold
9,557
0.15% 190
2016
Q4
$703K Buy
9,557
+180
+2% +$13.4K 0.14% 188
2016
Q3
$753K Hold
9,377
0.15% 187
2016
Q2
$738K Buy
9,377
+200
+2% +$15.1K 0.15% 182
2016
Q1
$661K Sell
9,177
-150
-2% -$11.3K 0.14% 184
2015
Q4
$786K Buy
9,327
+360
+4% +$29.9K 0.17% 162
2015
Q3
$750K Hold
8,967
0.17% 166
2015
Q2
$749K Hold
8,967
0.16% 175
2015
Q1
$651K Buy
8,967
+435
+5% +$31K 0.13% 189
2014
Q4
$589K Buy
8,532
+2,482
+41% +$168K 0.12% 186
2014
Q3
$392K Hold
6,050
0.1% 178
2014
Q2
$376K Hold
6,050
0.1% 174
2014
Q1
$356K Sell
6,050
-150
-2% -$8.37K 0.09% 180
2013
Q4
$316K Hold
6,200
0.09% 182
2013
Q3
$312K Hold
6,200
0.09% 178
2013
Q2
$305K Buy
+6,200
New +$337K 0.09% 172

Other funds holding LLY

Coastline Trust's LLY Position: Q1 2026 in Review

Coastline Trust increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $681K and bringing the position to 20,897 shares worth $19.2M. The position accounts for 1.91% of the portfolio, ranked #12.

Coastline Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Coastline Trust held 20,897 shares of Eli Lilly worth $19.2M as of Q1 2026.
  • Coastline Trust bought 672 Eli Lilly shares in Q1 2026, an estimated $681K.
  • Eli Lilly made up 1.91% of Coastline Trust's portfolio in Q1 2026, its #12 holding.
  • Coastline Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Coastline Trust's Eli Lilly position peaked at $21.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Coastline Trust's 13F filing for Q1 2026, filed 3 Apr 2026.